GIM
Grassi Investment Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20K | Hold |
18,000
| – | – | ﹤0.01% | 127 |
|
|
2025
Q1 | $14K | Hold |
18,000
| – | – | ﹤0.01% | 121 |
|
|
2024
Q4 | $30K | Hold |
18,000
| – | – | ﹤0.01% | 129 |
|
|
2024
Q3 | $63K | Hold |
18,000
| – | – | 0.01% | 126 |
|
|
2024
Q2 | $59K | Hold |
18,000
| – | – | 0.01% | 127 |
|
|
2024
Q1 | $132K | Hold |
18,000
| – | – | 0.01% | 122 |
|
|
2023
Q4 | $67K | Hold |
18,000
| – | – | 0.01% | 121 |
|
|
2023
Q3 | $38K | Hold |
18,000
| – | – | ﹤0.01% | 122 |
|
|
2023
Q2 | $86K | Hold |
18,000
| – | – | 0.01% | 124 |
|
|
2023
Q1 | $103K | Buy |
+18,000
| New | +$103K | 0.01% | 125 |
|